Isis Pharmaceuticals Inc (NASDAQ:ISIS)

During the Trading Day
54.40 +0.72 / +1.34%
As of 3:59pm ET
Day’s Change
During After-Hours   Switch to standard view »
54.01 -0.39 / -0.72%
Volume: 21.1K
Health Technology

Company Description

Isis Pharmaceuticals, Inc. engages in the development and commercialization of antisense drug discovery platform. It operates through the Drug Discovery and Development segment which exploits a novel drug discovery platform created to generate a broad pipeline of first-in-class drugs for the company and its partners. Its products are used to treat diseases such as severe and rare, cardiovascular, neurologic and metabolic diseases, and cancer. The company was founded by Stanley T. Crooke in January 1989 and is headquartered in Carlsbad, CA.

Contact Information

Isis Pharmaceuticals, Inc.
2855 Gazelle Court
Carlsbad California 92010
P:(760) 931-9200
Investor Relations:
(760) 603-2741



Individual stakeholders6.88%
Mutual fund holders53.69%
Other institutional31.98%

Top Executives

Stanley T. CrookeChairman, President & Chief Executive Officer
B. Lynne ParshallChief Operating Officer, Secretary & Director
Elizabeth L. HougenChief Financial Officer & SVP-Finance
C. Frank BennettSenior Vice President-Antisense Research
Brett P. MoniaSenior VP-Drug Discovery & Corporate Development

To view my watchlist

Not a member yet?

Sign up now for a free account